Atossa Genetics Inc. | Ownership
Companies that own Atossa Genetics Inc.
Sabby Capital LLC
340,749
6.72%
340,749
0.36%
06/30/2018
Anson Funds Management LP
108,977
2.15%
108,977
0.54%
06/30/2018
The Vanguard Group, Inc.
33,864
0.67%
0
0%
06/30/2018
G1 Execution Services LLC
24,162
0.48%
-1,023
0%
06/30/2018
Geode Capital Management LLC
15,769
0.31%
1,796
0%
06/30/2018
Iroquois Capital Management LLC
9,845
0.19%
-181,821
0.08%
12/31/2017
UBS Securities LLC
9,128
0.18%
5,896
0%
06/30/2018
DWS Investment GmbH
1,107
0.02%
1,106
0%
06/30/2018
BlackRock Fund Advisors
671
0.01%
1
0%
06/30/2018
Woodbury Financial Services, Inc.
416
0.01%
-1
0%
06/30/2018
| Address |
107 Spring Street
Seattle Washington 98104
United States
|
|
Employees
|
- |
| Website |
http://www.atossagenetics.com |
| Updated |
07/08/2019 |
| Atossa Genetics, Inc. operates as a clinical-stage pharmaceutical company, which focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. It offers ForeCYTE and ArgusCYTE diagnostic tests. The ForeCYTE Breast Health Test provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65. |
